Clear cell sarcoma of tendons and aponeuroses (malignant melanoma of soft parts) and cutaneous melanoma: Exploring the histogenetic relationship between these two clinicopathological entities

Journal of Pathology

Volumn 186, Issue 1, 1998, Pages 3-7

  Graadt Van Roggen, Jacob F ^a   Mooi, Wolter J ^b   Hogendoorn, Pancras C W ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Clear cell sarcoma of tendons and aponeuroses; Gene mutations; Histology; Melanoma

Indexed keywords

CELL ULTRASTRUCTURE; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 22; CLEAR CELL SARCOMA; GENE MUTATION; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MELANOMA; PRIORITY JOURNAL; REVIEW; SKIN BIOPSY; TENDON DISEASE;

EID: 0031674846     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199809)186:1<3::AID-PATH153>3.0.CO;2-V     Document Type: Review

References (43)

1. Enzinger FM. Clear cell sarcoma of tendons and aponeuroses. An analysis of 21 cases. Cancer 1965; 18: 1163-1174.
2. Bennet GA. Malignant neoplasms originating in synovial tissues (synoviomata). J Bone Joint Surg 1947; 29: 259-291.
3. Enzinger FM, Weiss SW (eds). Soft Tissue Tumours. 3rd edn. St Louis: CV Mosby, 1994.
4. Mooi WJ, Deenik W, Peterse JL, Hogendoorn PCW. Keratin immuno-reactivity in melanoma of soft parts (clear cell sarcoma). Histopathology 1995; 27: 61-65.
5. Miettinen M, Franssila K. Immunohistochemical spectrum of malignant melanoma. The common presence of keratins. Lab Invest 1989; 61: 623-628.
6. Kindblom L-G, Lodding P, Angervall L. Clear-cell sarcoma of tendons and aponeuroses. An immunohistochemical and electron microscopic analysis indicating neural crest origin. Virchows Arch A 1983; 401: 109-128.
7. Chung EB, Enzinger FM. Malignant melanoma of soft parts. A reassessment of clear cell sarcoma. Am J Surg Pathol 1983; 7: 405-413.
8. Montgomery E, Meis J, Ramos A, Frisman D, Mertz K. Clear cell sarcoma of tendons and aponeuroses. A clinicopathologic study of 58 cases with analysis of prognostic factors. Int J Surg Pathol 1993; 1: 89-100.
9. Lucas DR, Nascimento AG, Sim FH. Clear cell sarcoma of soft tissues. Mayo clinic experiences with 35 cases. Am J Surg Pathol 1992; 16: 1197-1204.
10. Tsuneyoshi M, Enjoji M, Kubo T. Clear cell sarcoma of tendons and aponeuroses. A comparative study of 13 cases with a provisional subgrouping into the melanotic and synovial types. Cancer 1978; 42: 243-252.
11. Sara AS, Evans HL, Benjamin RS. Malignant melanoma of soft parts (clear cell sarcoma). A study of 17 cases, with emphasis on prognostic factors. Cancer 1990; 65: 367-374.
12. Mooi WJ, Krausz T. Biopsy Pathology of Melanocytic Disorders. 1st edn. Chapman and Hall Medical, 1992.
13. Fletcher JA, Kozakewich HP, Hoffer FA, et al. Diagnostic relevance of clonal cytogenetic aberrations in malignant soft-tissue tumours. N Engl J Med 1991; 324: 436-442.
14. Molenaar WM, Dejong JB, Idenburg VJS, Seruca R, Vos AM, Hoekstra HJ. Chromosomal analysis and the classification of soft tissue sarcomas. Lab Invest 1989; 60: 266-274.
15. Ladanyi M. The emerging molecular genetics of sarcoma translocations. Diagn Mol Pathol 1995; 4: 162-173.
16. Fletcher JA. Cytogenetics and experimental models of sarcomas. Curr Opin Oncol 1994; 6: 367-371.
17. Limon J, Debiec-Rychter M, Nedoszytko B, Liberski P, Babinska M, Szadowska A. Aberrations of chromosome 22 and polysomy of chromosome 8 as non-random changes in clear cell sarcoma. Cancer Genet Cytogenet 1994; 72: 141-145.
18. Bridge JA, Sreekantaiah C, Neff JR, Sandberg AA. Cytogenetic findings in clear cell sarcoma of tendons and aponeuroses. Malignant melanoma of soft parts. Cancer Genet Cytogenet 1991; 52: 101-106.
19. Nedoszytko B, Mrozek K, Roszkiewicz A, Kopacz A, Siwerblewski M, Limon J. Clear cell sarcoma of tendons and aponeuroses with t(12;22)(q13;q12) diagnosed initially as malignant melanoma. Cancer Genet Cytogenet 1996; 91: 37-39.
20. Mrozek K, Karakousis CP, Perez-Mesa C, Bloomfield CD. Translocation t(12;22)(q13;q12.2-12.3) in a clear cell sarcoma of tendons and aponeuroses. Genes Chrom Cancer 1993; 6: 249-252.
21. Peulve P, Michot C, Vannier J-P, Tron P, Hemet J. Clear cell sarcoma with t(12;22)(q13-14;q12). Genes Chrom Cancer 1991; 3: 400-402.
22. Stenman G, Kindblom L-G, Angervall L. Reciprocal translocation t(12;22)(q13;q13) in clear-cell sarcoma of tendons and aponeuroses. Genes Chrom Cancer 1992; 4: 122-127.
23. Bridge JA, Borek DA, Neff JR, Huntrakoon M. Chromosomal abnormalities in clear cell sarcoma. Implications for histogenesis. Am J Clin Pathol 1990; 93: 26-31.
24. Speleman F, Colapaert C, Goovaerts G, Leroy JG, van Marck E. Malignant melanoma of soft parts. Further cytogenetic characterization. Cancer Genet Cytogenet 1992; 58: 176-179.
25. Travis JA, Bridge JA. Significance of both numerical and structural chromosomal abnormalities in clear cell sarcoma. Cancer Genet Cytogenet 1992; 64: 104-106.
26. Speleman F, Delattre O, Peter M, Hauban E, van Roy N, van Marck E. Malignant melanoma of the soft parts (clear cell sarcoma): confirmation of EWS and ATF-1 gene fusion caused by a t(12;22) translocation. Mod Pathol 1997; 10: 496-499.
27. Epstein IL, Martin AO, Kempson R. Use of a newly established cell line (SU-CCS-1) to demonstrate the relationship of clear cell sarcoma to malignant melanoma. Cancer Res 1984; 44: 1265-1274.
28. Liao S-K. Perng Y-P, Lee L-A, et al. Newly established MST-1 tumour cell line and tumour-infiltrating lymphocyte culture from a patient with soft tissue melanoma (clear cell sarcoma) and their potential applications to patient immunotherapy. Eur J Cancer 1996; 32A: 346-356.
29. Takenouchi T, Ito K, Kazama T, Ito M. Establishment and characterization of a clear-cell sarcoma (malignant melanoma) cell line. Arch Dermatol Res 1994; 286: 254-260.
30. Reeves BR, Fletcher CDM, Custerson BA. Translocation t(12;22)(q13;q13) is a nonrandom rearrangement in clear cell sarcoma. Cancer Genet Cytogenet 1992; 64: 101-103.
31. Rodriguez E. Sreekantaiah C, Reuter VE, Motzer RJ, Chaganti RSK. t(12;22)(q13;q13) and trisomy 8 are nonrandom aberrations in clear-cell sarcoma. Cancer Genet Cytogenet 1992; 64: 107-110.
32. Pathak S, Drwinga HL, Hsu TC. Involvement of chromosome 6 in rearrangements in human malignant melanoma cell lines. Cytogenet Cell Genet 1983; 36: 573-579.
33. Quinn LA, Woods LK, Merrick SB, Arabasz NM, Moore GE. Cytogenetic analysis of 12 malignant melanoma cell lines. J Natl Cancer Inst 1977; 59: 301-307.
34. Pedersen MI, Bennett JW, Wang N. Nonrandom chromosomes, structural aberrations, and oncogene loci in human malignant melanoma. Cancer Genet Cytogenet 1985; 20: 11-27.
35. Trent JM, Rosenfeld SB, Meyskens FL. Chromosome 6q involvement in malignant melanoma. Cancer Genet Cytogenet 1983; 9: 177-180.
36. Balaban G, Herlyn M, Dupont G, et al. Cytogenetics of human malignant melanoma and premalignant lesions. Cancer Genet Cytogenet 1984; 11: 429-439.
37. Muir PD, Gunz FW. A cytogenetic study of 8 human melanoma cell lines. Pathology 1979; 11: 597-606.
38. El-Naggar AK, Ordonez NG, Sara A, McLemore D, Batsakis JG. Clear cell sarcomas and metastatic soft tissue melanomas. A flow cytometric comparison and prognostic implications. Cancer 1991; 67: 2173-2179.
39. Ropers H-H, Craig IW. Report of the committee on the genetic constitution of chromosomes 12 and 13. Cytogenet Cell Genet 1989; 51: 259-279.
40. Desmaze C, Zucman J, Delattre O, Melot T, Thomas G, Aurias A. Precise localization on chromosome 12 of the ATF-1 gene by fluorescence in situ hybridization. Hum Genet 1994; 93: 207-208.
41. Kaplan J-C, Emanuel BS. Report of the committee on the genetic constitution of chromosome 22. Cytogenet Cell Genet 1989; 51: 372-383.
42. Delattre O, Zucman J, Plougastel B, et al. Gene fusion with an ETS DNA-binding domain caused by chromosome translocation in human tumours. Nature 1992; 359: 162-164.
43. Zucman J, Delattre O, Desmaze C, et al. EWS and ATF-1 gene fusion induced by t(12;22) translocation in malignant melanoma of soft parts. Nature Genet 1993; 4: 341-345.